Cannabis Crackdown : New York Investigates Major Cannabis Brands
New York is turning up the heat on some of the biggest cannabis brands in the country, launching an investigation into claims that they’ve been selling weed sourced from outside the state—something that’s very much illegal.
At the center of the investigation is a practice called “inversion,” which has become pretty common in the cannabis industry. Basically, it’s when companies bypass state rules by bringing in cheaper weed from out of state or buying it from unlicensed growers, then sneak it into the legal market. It saves them money but seriously undercuts local farmers and compromises consumer safety. And now, New York’s cannabis regulators are finally stepping in to do something about it.
According to people familiar with the situation, the Office of Cannabis Management (OCM) is focusing on several major cannabis brands, including Stiiizy, the top-selling weed brand in the U.S. Regulators believe these companies may be working with Omnium Canna, a processor based on Long Island, to move out-of-state weed into New York’s legal market.
Since February, the OCM has been quietly looking into the issue, but things escalated this past Monday when inspectors conducted surprise audits at two of Omnium’s facilities. The inspections were pretty serious—inspectors wearing “compliance” jackets showed up with clipboards and visited both sites. This is a big deal because under federal law, cannabis can’t be transported across state lines, even if it’s legal in both states. That means anything sold legally in New York has to be grown, processed, and sold entirely within the state.
The issue goes beyond just legal violations. Inversion makes it harder for consumers to know where their weed is coming from and whether it’s been safely tested. Products that are supposed to go through licensed New York labs might be coming from who-knows-where, with who-knows-what in them. That’s a serious concern, especially when safety and traceability are some of the main selling points of legalized cannabis.
Meanwhile, licensed growers in New York are feeling the squeeze. Many of them are sitting on unsold product because they can’t compete with the cheaper, potentially illegal supply flooding the market. The Cannabis Farmers Alliance, a group representing local growers, estimates that up to 70% of the weed sold in licensed dispensaries might actually be illicit. That’s a huge problem for small farmers trying to survive in a brand-new and already competitive market.
Despite all this, the brands being investigated—like Stiiizy, Waahoo, Grön, Mfused, To the Moon, and Turn—have denied any wrongdoing. They say the audits were just routine inspections and insist their operations are above board. In a statement, Stiiizy’s CEO said the company has never sourced cannabis from out of state and is fully compliant with New York regulations.
Still, the state seems to be taking this seriously. The OCM recently created a Trade Practices Bureau to look into issues like inversion and market manipulation, suggesting they’re planning to step up enforcement. They haven’t released any findings from the investigation yet, but the timing—just weeks before 4/20, the unofficial cannabis holiday—definitely sends a message.
Adding to the tension is a 2,000+ page whistleblower report that points to inconsistencies in lab results and product labels, which could be grounds for recalls or quarantines. Some of the products in question include vapes and edibles that require ingredients and equipment that are hard to get legally in New York, which only adds to suspicions.
Experts and insiders say this kind of thing has been going on for a while and that the lack of a proper statewide “track-and-trace” system makes it easier to get away with. Without a way to trace products back to their source, regulators are basically playing catch-up.
So, what’s next? If the state finds that these brands did break the rules, they could face penalties, lose their licenses, or be banned from the New York market entirely. That could have ripple effects across the national cannabis scene, especially if other states start looking more closely at how these companies operate.
For now, New York’s cannabis industry is holding its breath. Whether this investigation leads to real change—or just more confusion—remains to be seen.
See more here